Rigrodsky & Long, P.A. Investigates Clarient, Inc. Buyout
Rigrodsky & Long, P.A. announces that it is investigating potential claims against the board of directors of Clarient, Inc. (“Clarient” or the “Company”) (Nasdaq: CLRT) concerning possible breaches of fiduciary duty and other violations of law related to the Company’s entry into an agreement to be acquired by GE Healthcare (“GE”) in a transaction valued at approximately $580 million. Click here to learn how to join the action: http://www.rigrodskylong.com/news/ClarientInc-CLRT.
Under the proposed agreement, a subsidiary of GE will commence a cash tender offer for all outstanding common and preferred shares of Clarient at $5.00 per common share and $20.00 per preferred share, in each case payable in cash. GE will then acquire any Clarient shares not purchased in the tender offer in a second-step merger at the same price per share paid in the tender offer.
The investigation concerns whether Clarient’s board of directors failed to adequately shop the Company and obtain the best price possible for Clarient’s shareholders before entering into the agreement with GE. Indeed, shareholders holding approximately 47% of Clarient’s current outstanding voting stock have agreed, among other things, to tender their shares in the proposed transaction. Moreover, according to Yahoo! Finance, at least one analyst has set a price target of $6.00 per share for Clarient stock.
If you own the common stock of Clarient and purchased your shares before October 22, 2010, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Seth D. Rigrodsky, Esquire or Noah R. Wortman, Case Development Director, of Rigrodsky & Long, P.A., 919 N. Market Street, Suite 980, Wilmington, Delaware, by telephone at (888) 969-4242, or by e-mail to firstname.lastname@example.org.Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV